Zaleplon vs Temazepam (Restoril) vs Zolpidem (Ambien): Which to Choose?
For sleep-onset insomnia, use zaleplon 10 mg or zolpidem 10 mg; for sleep maintenance insomnia, use zolpidem 10 mg or temazepam 15 mg; for combined sleep-onset and maintenance problems, use zolpidem 10 mg or temazepam 15 mg. All three medications carry weak recommendations from the American Academy of Sleep Medicine, meaning your clinical judgment and patient-specific factors should guide the final choice 1.
Algorithm for Selection
Step 1: Identify the Primary Sleep Problem
Sleep-onset insomnia only (difficulty falling asleep):
First choice: Zaleplon 10 mg 1
Alternative: Zolpidem 10 mg 1
- Also effective for sleep onset
- Longer duration than zaleplon, so provides some sleep maintenance benefit
- Higher risk of next-morning cognitive impairment than zaleplon 4
Sleep maintenance insomnia (frequent awakenings, early morning awakening):
First choice: Zolpidem 10 mg 1
- Addresses both onset and maintenance
- Half-life ~2.4 hours provides coverage through most of the night 5
Alternative: Temazepam 15 mg 1
Combined sleep-onset AND maintenance problems:
First choice: Zolpidem 10 mg 1
- Covers both phases of sleep
- Better next-day performance profile than temazepam 4
Second choice: Temazepam 15 mg 1
Step 2: Consider Patient-Specific Risk Factors
Elderly patients (≥65 years):
- Reduce all doses by 50%: zaleplon 5 mg, zolpidem 5 mg, temazepam 7.5 mg
- Prefer zaleplon due to minimal next-day effects and lower fall risk 8
- Avoid temazepam if possible—benzodiazepines carry increased risk of cognitive impairment, falls, fractures, and dementia in older adults 9, 8
Women:
- FDA mandates lower zolpidem doses (5 mg) due to slower drug metabolism 9
- Zaleplon and temazepam dosing remains standard
History of substance abuse:
- All three are controlled substances (Schedule IV)
- Temazepam carries highest abuse potential as a benzodiazepine 10
- Prefer zaleplon or zolpidem if abuse history exists
Need for middle-of-the-night dosing:
- Only zaleplon is appropriate for middle-of-the-night use (if ≥4 hours remain before waking) 2, 8
- Zolpidem and temazepam will cause morning impairment if taken after initial bedtime
Concern about driving/morning performance:
- Zaleplon is safest—no next-day impairment at 5-10 mg doses 11
- Zolpidem causes measurable morning DSST impairment 4
- Temazepam causes the most morning sedation and cognitive slowing 4, 6
Critical Safety Considerations
Complex Sleep Behaviors (All Three Drugs)
All three medications can cause sleep-driving, sleep-eating, and other complex behaviors while not fully awake 2, 10. Absolute contraindications:
- Prior history of complex sleep behavior on any hypnotic
- Concurrent alcohol use
- Concurrent use of other CNS depressants (unless specifically approved by prescriber)
Benzodiazepine-Specific Risks (Temazepam Only)
Temazepam carries additional risks not seen with zaleplon or zolpidem 10:
- Physical dependence develops more readily
- Withdrawal syndrome can be severe (seizures, delirium, suicidal ideation)
- Never stop abruptly—taper over weeks if used >2 weeks
- Associated with increased dementia risk in observational studies 9
Duration of Treatment
- All three are FDA-approved for SHORT-TERM use only (7-10 days for temazepam 10, 2-4 weeks for zaleplon and zolpidem)
- No evidence supports long-term efficacy beyond 4 weeks 9
- Tolerance did not develop with zaleplon in studies up to 12 months 11, but this doesn't justify chronic use
Comparative Efficacy: What the Evidence Shows
The 2017 AASM guidelines give weak recommendations for all three agents, meaning the evidence quality is low and effect sizes are small 1. The 2016 American College of Physicians review found insufficient evidence to compare efficacy between these drugs directly 9.
Head-to-head studies reveal:
- Zolpidem vs. temazepam: No difference in rebound insomnia after 4 weeks 7; zolpidem showed better subjective sleep quality but worse morning DSST performance 4
- Temazepam vs. zaleplon: Temazepam provided longer, better quality afternoon sleep in shift-work model, but both caused nighttime sleepiness equally 6
- Zaleplon has the most favorable pharmacokinetic profile for avoiding residual effects due to its 1-hour half-life 3, 11
What NOT to Do
Avoid temazepam as first-line unless:
- Patient has failed zaleplon and zolpidem
- Sleep maintenance is the predominant problem AND patient can tolerate morning sedation
- Patient is not elderly
Do not use any of these medications:
- For longer than 4 weeks without reassessment
- In combination with alcohol or opioids
- Without counseling about complex sleep behaviors
- In patients with a history of complex sleep behaviors on hypnotics
Do not assume "no rebound" means safe discontinuation—even zaleplon and zolpidem can cause withdrawal symptoms if used nightly for extended periods, though less severe than temazepam 7, 11.
The Bottom Line
Zaleplon wins for safety profile (minimal residual effects, flexible dosing timing, suitable for elderly) but only treats sleep onset 1, 11, 8. Zolpidem is the most versatile for treating both onset and maintenance with acceptable next-day effects 1, 5. Temazepam should be reserved for refractory cases due to benzodiazepine-related harms including cognitive impairment, falls, dependence, and potential dementia risk 9, 10, 8.
All three carry risks of complex sleep behaviors and should be prescribed at the lowest effective dose for the shortest duration necessary 9, 2, 10. The choice ultimately depends on whether the patient needs help falling asleep, staying asleep, or both—and their individual risk profile for adverse effects.